Home
April 2008 May 2008 June 2008
Su Mo Tu We Th Fr Sa
Week 18 1 2 3
Week 19 4 5 6 7 8 9 10
Week 20 11 12 13 14 15 16 17
Week 21 18 19 20 21 22 23 24
Week 22 25 26 27 28 29 30 31

Penile Traction Therapy for Treatment of Peyronie's Disease: A Single-Center Pilot Study - Abstract Show Comments PDF Print E-mail
  
Wednesday, 09 April 2008

Department of Urology, Rush University Medical Center, Chicago, IL, USA.

Peyronie's disease (PD) is a fibrotic disorder of the penis whose etiopathophysiology remains unclear. At this time, there is no known reliable nonsurgical treatment. This study reviews our experience with external penile traction therapy to correct the deformity associated with this disorder.

To evaluate prolonged external penile traction as a nonsurgical treatment for PD. Methods. Ten men with PD completed this noncontrolled pilot study of traction therapy using the FastSize Penile Extender. Nearly all (90%) had failed prior medical therapy. Traction was applied as the only treatment for 2-8 hours/day for 6 months. All subjects underwent pre- and post-treatment physical examination including measurement of stretched flaccid penile length (SPL) and biothesiometry.

Curvature and girth were measured during erection before and after treatment with dynamic duplex ultrasound. Assessment of erectile and sexual function was further assessed with the International Index of Erectile Function and Quality of Life Specific to Male Erection Difficulties (QOL-MED) questionnaires. At 3 and 6 months post-treatment, SPL was measured and subjective assessment of deformity by the patient was recorded.

Subjectively all men noted reduced curvature estimated at 10-40 degrees, increased penile length (1-2.5 cm) and enhanced girth in areas of indentation or narrowing. Objective measures demonstrated reduced curvature in all men from 10-45 degrees; average reduction for the group was 33% (51-34 degrees). SPL increased 0.5-2.0 cm and erect girth increased 0.5-1.0 cm with correction of hinge effect in four out of four men. International Index of Erectile Function-erectile function domain increased from 18.3-23.6 for the group. Changes in quality of life by QOL-MED were not found to be statistically significant in this small series. There were no adverse events including skin changes, ulcerations, hypoesthesia or diminished rigidity.

Prolonged daily external penile traction therapy is a new approach for the nonsurgical treatment of PD. Further study appears warranted given the response noted in this pilot study.

Written by
Levine LA, Newell M, Taylor FL.

Reference
J Sex Med. 2008 Mar 21. Epub ahead of print.
doi:10.1111/j.1743-6109.2008.00814.x

PubMed Abstract
PMID:18373527

UroToday.com Peyronie's Disease Section

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 7
PoorBest


 
Visitor Ratings:
Healthcare Professionals:
5 (2 votes)

Patients:
5 (4 votes)

No Affiliation:
4 (3 votes)